Biomedical engineers at Duke University have successfully generated retinal blood vessel cells from induced pluripotent stem cells and restored vision in mice with eye disease. When transplanted into damaged retinal tissue, these lab-grown endothelial cells integrated seamlessly and regenerated functional blood vessels, reversing vision loss in the animal models.
This breakthrough represents a significant advancement toward clinical treatments for devastating blinding conditions, including diabetic retinopathy, age-related macular degeneration, and other retinal vascular diseases. The successful integration of lab-grown cells into living tissue demonstrates the viability of cell-based regenerative approaches for ophthalmology.
Research teams anticipate that human clinical trials could commence within 3 to 5 years, pending regulatory approval and further safety validation. This achievement marks a crucial milestone in translating stem cell research from the laboratory bench to patient care.
Was this article helpful?
